Skip to NavigationSkip to content

takeover

MSD joins Medivation race, says reports

MSD, known as Merck in the US and Canada, is said to have declared its interest in buying US oncology drugs firm Medivation, according to a report by Reuters.

Takeover rumours send Biogen’s stock soaring

Rumours have begun to circulate that companies including MSD and Allergan are plotting a takeover bid for Biogen, after a Wall Street Journal cited people familiar with the matter.

Any deal for Biogen would easily be one of the largest in the industry’s history. After the initial talk emerged over a potential takeover bid, Biogen stock rose almost 10% to $330 per share, with a market cap of $75.3 billion.

China’s Fosun seals $1.3 billion deal for Gland Pharma

Fosun Pharmaceutical has agreed a deal to purchase an 86.1% stake of Gland Pharma, which will see the Chinese firm acquire a new range of injectable medicines as well as manufacturing facilities in India.

Gland has entered European and US markets with its product range which includes heart drug amiodarone and antiplatelet drug Tirofiban. They have four facilities, mainly based in Hyderabad, which manufacture a variety of injectables.

Busy week at Juno Therapeutics ends with takeover of RedoxTherapies

Juno Therapeutics (NASDAQ: JUNO) has announced the acquisition of RedoxTherapies, adding its lead cancer drug candidate, vipadenant, to its portfolio.

Sanofi looks to set date for showdown with Medivation shareholders

Sanofi (NYSE: SNY) has announced that it has attempted to fix a record date with Medivation (NASDAQ: MDVN) where the shareholders at the company can decide whether or not to remove and replace the board in favour of members hand-picked by the French pharma company.

Sanofi makes move to remove Medivation board; Medivation hits back

Sanofi (NYSE: SNY) has taken their proposed takeover of Medivation (NASDAQ: MDVN) up several notches, with the French company filing preliminary consent solicitation materials with the US Securities and Exchange Commission seeking to remove and replace each member of Medivation’s board of directors.

Sanofi has proposed eight individuals who would take the place of the current Medivation board, who they say “are willing to fully and fairly evaluate all of Medivation’s strategic options, including Sanofi’s acquisition offer.”

Bayer makes bid for Monsanto

Bayer (ETR: BAYN) has made a move to consolidate its position in the agrochemical sector with an unsolicited takeover bid for Monsanto (NYSE: MON).

The American company has a market cap of $42.19 billion and has a range of agricultural products in its portfolio, which would complement Bayer’s strength in animal and crop sciences.

Sanofi to replace entire Medivation board to drive sale, according to reports

Reports have emerged that Sanofi is looking to step up its efforts to take over oncology firm, Medivation, as it set to propose eight new members to the board.

The current board at Medivation have strongly opposed a sale, claiming that Sanofi’s offer “significantly undervalues” the company. Last week, Sanofi CEO Olivier Brandicourt wrote a letter to the board indicating that they would take steps to remove the board at Medivation if they refused to engage on a potential deal.

BTG acquires promising oncology pipeline in Galil Medical takeover

BTG (LSE: BTG) has announced that is has agreed to acquire Galil Medical, a leading provider of cryoablation products for the treatment and palliative care of kidney and other cancers.

The process of using extreme cold to destroy or damage tissue has shown promise in fighting against tumours. As compressed gas passed through the needle, the tip of the needle is cooled which forms an ice ball that engulfs the tumour and destroys the tissue.

Focus: Medivation tug-of-war rumbles on

Published on 06/05/16 at 09:24am

Medivation (NASDAQ: MDVN) has been making all the headlines as a list of suitors’ line up, all vying to secure a multi-billion dollar deal to buy the firm.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches